Clinical Research: Response Markers and Mechanisms

Contributing journals to this collection:
Cancer Prevention Journals Portal, Cancer Prevention Journals Portal Content, , Cancer Reviews Online, Molecular Cancer Research, Cancer Prevention Research, Molecular Cancer Therapeutics, Cancer Research, Cancer Reviews Online Content, Clinical Cancer Research, and Cancer Epidemiology Biomarkers & Prevention

Citations 11-20 of 29 total displayed.

Past content

Review
Clinical Implications of CYP2D6 Genotyping in Tamoxifen Treatment for Breast Cancer

Vincent O. Dezentjé, Henk-Jan Guchelaar, Johan W.R. Nortier, Cornelis J.H. van de Velde, and Hans Gelderblom
Clin. Cancer Res. 2009; 15: 15-21. [Abstract] [Full text] [PDF]  

CCR Focus
Genetic Susceptibility Loci for Breast Cancer by Estrogen Receptor Status

Montserrat Garcia-Closas and Stephen Chanock
Clin. Cancer Res. 2008; 14: 8000-8009. [Abstract] [Full text] [PDF]  

CCR Focus
Emerging Biomarkers and New Understanding of Traditional Markers in Personalized Therapy for Breast Cancer

Mitch Dowsett and Anita K. Dunbier
Clin. Cancer Res. 2008; 14: 8019-8026. [Abstract] [Full text] [PDF]  

CCR Focus
Validation of Analytic Methods for Biomarkers Used in Drug Development

Cindy H. Chau, Olivier Rixe, Howard McLeod, and William D. Figg
Clin. Cancer Res. 2008; 14: 5967-5976. [Abstract] [Full text] [PDF]  

CCR Special Focus
Translational Research Working Group Developmental Pathway for Biospecimen-Based Assessment Modalities

Sudhir Srivastava, Joe W. Gray, Brian J. Reid, Oren Grad, Addison Greenwood, Ernest T. Hawk for the Translational Research Working Group
Clin. Cancer Res. 2008; 14: 5672-5677. [Abstract] [Full text] [PDF]  

Subject Reviews
Systems-Level Analysis of ErbB4 Signaling in Breast Cancer: A Laboratory to Clinical Perspective

Chih-Pin Chuu, Rou-Yu Chen, John L. Barkinge, Mark F. Ciaccio, and Richard B. Jones
Mol. Cancer Res. 2008; 6: 885-891. [Abstract] [Full text] [PDF]  

Reviews
Identifying Breast Cancer Druggable Oncogenic Alterations: Lessons Learned and Future Targeted Options

Alberto Ocaña and Atanasio Pandiella
Clin. Cancer Res. 2008; 14: 961-970. [Abstract] [Full text] [PDF]  

CCR Focus
Is Cell Death a Critical End Point for Anticancer Therapies or Is Cytostasis Sufficient?

Olivier Rixe and Tito Fojo
Clin. Cancer Res. 2007; 13: 7280-7287. [Abstract] [Full text] [PDF]  

Reviews
Emerging Roles of MUC4 in Cancer: A Novel Target for Diagnosis and Therapy

Ajay P. Singh, Pallavi Chaturvedi, and Surinder K. Batra
Cancer Res. 2007; 67: 433-436. [Abstract] [Full text] [PDF]  

Review
Spindle checkpoint function and cellular sensitivity to antimitotic drugs

Hiroshi Y. Yamada and Gary J. Gorbsky
Mol. Cancer Ther. 2006; 5: 2963-2969. [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3